Literature DB >> 20516125

Interaction between adiponectin and leptin influences the risk of colorectal adenoma.

Taiki Yamaji1, Motoki Iwasaki, Shizuka Sasazuki, Shoichiro Tsugane.   

Abstract

Obesity has been associated with an increased risk of colorectal neoplasia, but the mechanisms of this potential association have not been elucidated. We hypothesized that the adipokines adiponectin, leptin, and tumor necrosis factor-alpha (TNF-alpha) may mediate an association between obesity and colorectal cancer. We measured plasma concentrations of total and high-molecular-weight (HMW) adiponectin, leptin, and TNF-alpha in healthy volunteer examinees who underwent total colonoscopy between February 2004 and February 2005, and conducted a case-control study consisting of 778 cases and 735 controls. An inverse association of total and HMW adiponectin was observed with colorectal adenoma (P trend < 0.001 and 0.03, respectively). Further, total adiponectin interacted with leptin, but not TNF-alpha, in relation to colorectal adenoma (P interaction = 0.007). An inverse association of total adiponectin with colorectal adenoma was apparent in the highest two tertiles of leptin, particularly the middle (P trend < 0.001), whereas a positive association of leptin was obvious in the lowest tertile of total adiponectin (P trend = 0.01) after adjusting for potential confounders and body mass index, which is a major determinant of insulin resistance. Adiponectin may exert an anticarcinogenic effect on the large intestine by interfering with leptin, whereas leptin could conversely exert a carcinogenic effect under conditions of a lower abundance of adiponectin. Our findings provide the first epidemiologic evidence for interactive effects of adiponectin and leptin in the early stage of colorectal tumorigenesis, distinct from their involvement in insulin resistance. Copyright 2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20516125     DOI: 10.1158/0008-5472.CAN-10-0178

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  57 in total

Review 1.  The balance between leptin and adiponectin in the control of carcinogenesis - focus on mammary tumorigenesis.

Authors:  Michael E Grossmann; Margot P Cleary
Journal:  Biochimie       Date:  2012-06-20       Impact factor: 4.079

Review 2.  Body mass index and colon cancer screening: the road ahead.

Authors:  Kanwarpreet Tandon; Mohamad Imam; Bahaa Eldeen Senousy Ismail; Fernando Castro
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

3.  Comparison of plasma levels of nutrient-related biomarkers among Japanese populations in Tokyo, Japan, São Paulo, Brazil, and Hawaii, USA.

Authors:  Motoki Iwasaki; Adrian A Franke; Gerson S Hamada; Nelson T Miyajima; Sangita Sharma; Junko Ishihara; Ribeka Takachi; Shoichiro Tsugane; Loïc Le Marchand
Journal:  Eur J Cancer Prev       Date:  2015-03       Impact factor: 2.497

Review 4.  Multifaceted roles of adiponectin in cancer.

Authors:  Lionel Hebbard; Barbara Ranscht
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2013-11-22       Impact factor: 4.690

5.  Mechanisms by Which Pleiotropic Amphiphilic n-3 PUFA Reduce Colon Cancer Risk.

Authors:  Robert S Chapkin; Vanessa DeClercq; Eunjoo Kim; Natividad Roberto Fuentes; Yang-Yi Fan
Journal:  Curr Colorectal Cancer Rep       Date:  2014-12-01

6.  AdipoRon Attenuates Wnt Signaling by Reducing Cholesterol-Dependent Plasma Membrane Rigidity.

Authors:  Michael L Salinas; Natividad R Fuentes; Rachel Choate; Rachel C Wright; David N McMurray; Robert S Chapkin
Journal:  Biophys J       Date:  2019-09-16       Impact factor: 4.033

Review 7.  Obesity, energy balance, and cancer: new opportunities for prevention.

Authors:  Stephen D Hursting; John Digiovanni; Andrew J Dannenberg; Maria Azrad; Derek Leroith; Wendy Demark-Wahnefried; Madhuri Kakarala; Angela Brodie; Nathan A Berger
Journal:  Cancer Prev Res (Phila)       Date:  2012-10-03

8.  Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status.

Authors:  Kentaro Inamura; Mingyang Song; Seungyoun Jung; Reiko Nishihara; Mai Yamauchi; Paul Lochhead; Zhi Rong Qian; Sun A Kim; Kosuke Mima; Yasutaka Sukawa; Atsuhiro Masuda; Yu Imamura; Xuehong Zhang; Michael N Pollak; Christos S Mantzoros; Curtis C Harris; Edward Giovannucci; Charles S Fuchs; Eunyoung Cho; Andrew T Chan; Kana Wu; Shuji Ogino
Journal:  J Natl Cancer Inst       Date:  2015-11-23       Impact factor: 13.506

Review 9.  Adiponectin and colorectal cancer.

Authors:  Kensuke Otani; Soichiro Ishihara; Hironori Yamaguchi; Koji Murono; Koji Yasuda; Takeshi Nishikawa; Toshiaki Tanaka; Tomomichi Kiyomatsu; Keisuke Hata; Kazushige Kawai; Hiroaki Nozawa; Toshiaki Watanabe
Journal:  Surg Today       Date:  2016-04-09       Impact factor: 2.549

10.  Plasma adiponectin and soluble leptin receptor and risk of colorectal cancer: a prospective study.

Authors:  Mingyang Song; Xuehong Zhang; Kana Wu; Shuji Ogino; Charles S Fuchs; Edward L Giovannucci; Andrew T Chan
Journal:  Cancer Prev Res (Phila)       Date:  2013-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.